Home
About
Overview
Sharing Data
ORCID
Help
History (9)
What's best for IBS?
ANTIBODY-INDUCED GLOMERULAR BASEMENT MEMBRANE INJURY
Incidence of serious bleeding events (sBE) in patients (pts) with metastatic colorectal cancer (mCRC) receiving bevacizumab (BV) as part of a first-line regimen: Results from the BRiTE observational cohort study (OCS).
Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients (pts) with metastatic colorectal cancer (mCRC): Results from the BRiTE observational cohort study.
Principal Investigator
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Salgia, Ravi
One or more keywords matched the following items that are connected to
Salgia, Ravi
Item Type
Name
Concept
Protein Tyrosine Phosphatase, Non-Receptor Type 6
Concept
Protein Tyrosine Phosphatase, Non-Receptor Type 11
Concept
Protein Tyrosine Phosphatase, Non-Receptor Type 12
Academic Article
The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors.
Academic Article
The noncatalytic domain of protein-tyrosine phosphatase-PEST targets paxillin for dephosphorylation in vivo.
Academic Article
A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion.
Search Criteria
Protein Tyrosine Phosphatase Non Receptor Type 4